A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on pharmacovigilance

Author： Ladds Graeme  

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.11, Iss.1, 2004-10, pp. : 44-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical trials in the pharmaceutical industry: The scope of the research exemption under French patent law – clarification is still awaited

By Cousté M  

Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. : 67-71

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Biodiesel production with special emphasis on lipase-catalyzed transesterification

By Bisen Prakash  

Biotechnology Letters, Vol. 32, Iss. 8, 2010-08 ,pp. : 1019-1030

Springer Publishing Company

Access to resources Recommend Favorite

The roles and responsibilities of the EU qualified person for pharmacovigilance under Volume IXa March 2007

By Ladds Graeme  

Journal of Commercial Biotechnology, Vol. 13, Iss. 4, 2007-08 ,pp. : 259-262

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

eClinical trials: The future is now

By Marks R G  

Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. : 49-58

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Antisense oligonucleotides: towards clinical trials

By Agrawal S.  

Trends in Biotechnology, Vol. 14, Iss. 10, 1996-10 ,pp. : 376-387

Elsevier

Access to resources Recommend Favorite